June 8, 2020 Life Science Tools Product Launch

Bio-Techne Announces Release of GMP ProDots Proteins to Support Cell and Gene Therapy Manufacturing Workflows

MINNEAPOLIS, June 8, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the release of GMP ProDots™ Proteins to support cell and gene therapy manufacturing workflows. GMP ProDots™ Proteins address a critical need to precisely dose and safely add essential proteins such as growth factors and cytokines to therapeutic cell cultures. GMP ProDots Proteins, produced under GMP-grade conditions... Read more

June 3, 2020 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Swift Biosciences and Arbor Biosciences Partner on Targeted NGS Workflows for Coronavirus

ANN ARBOR, Mich. June 3, 2020 /PRNewswire/ — Swift Biosciences and Arbor Biosciences, a division of Chiral Technologies, jointly announced a partnership to offer a complete workflow for RNA-Seq library preparation and targeted enrichment of the SARS-CoV-2 genome. An enabling offering for epidemiological research and public health surveillance, the partnership leverages Swift’s patented Adaptase® technology... Read more

June 3, 2020 Life Science Tools M&A, Partnerships

Swift Biosciences and Arbor Biosciences Partner on Targeted NGS Workflows for Coronavirus

ANN ARBOR, Mich. June 3, 2020 /PRNewswire/ — Swift Biosciences and Arbor Biosciences, a division of Chiral Technologies, jointly announced a partnership to offer a complete workflow for RNA-Seq library preparation and targeted enrichment of the SARS-CoV-2 genome. An enabling offering for epidemiological research and public health surveillance, the partnership leverages Swift’s patented Adaptase® technology... Read more

May 28, 2020 Clinical Research/Diagn. Life Science Tools Product Launch

Swift Biosciences Enables COVID-19 Surveillance With NGS of Low Titer SARS-CoV-2 Specimens

ANN ARBOR, Mich. – May 28, 2020 — Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), has announced the release of its Swift Normalase™ Amplicon Panel (SNAP) SARS-CoV-2 kit. Targeting the full viral genome in a single tube reaction with a rapid 2-hour workflow, Swift’s... Read more

May 26, 2020 Cell Analysis Tools Life Science Tools Product Launch

Product Launch: CytoSMART Technologies announces the launch of the CytoSMART Lux2 Duo Kit

Caption: CytoSMART Lux2 Duo Kit offers side-by-side comparisons between cell cultures. To download this image, click here. 26 May 2020, Eindhoven, The Netherlands – Life Science Newswire – CytoSMART Technologies today announced the launch of a new live-cell imaging system. The CytoSMART Lux2 Duo Kit offers a straightforward, cost-effective solution for researchers carrying out immediate side-by-side comparisons between cell cultures.... Read more

May 26, 2020 Life Science Tools PR/Corporate

Oxford Nanopore announces £48.4M ($59.2M) in new capital to support ongoing innovation and the rapid worldwide growth of nanopore sequencing

Tue 26th May 2020 26th May 2020, Oxford, UK:  Oxford Nanopore Technologies has raised £48.4M ($59.2M) in new capital. The funding comes from new investors and existing shareholders in EMEA, US and Asia, and adds to the £29M of new capital raised in Q4 2019.   Further information on Oxford Nanopore’s fundraising will be made... Read more

May 26, 2020 Clinical Research/Diagn. Life Science Tools Product Launch

Leica Biosystems and Bio-Techne Announce European Launch of the CE-IVD RNAscope in Situ Hybridization Detection Kit

MAY 26, 2020 The CE-IVD marked system will enable diagnostic pathologists with new applications MINNEAPOLIS, May 26, 2020 /PRNewswire/ — Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities and Leica Biosystems, a global leader in workflow solutions and automation, are proud to announce... Read more

May 22, 2020 Life Science Tools Product Launch

Oxford Nanopore Technologies announces advanced development of LamPORE, for rapid, highly scalable, low-cost COVID-19 detection

Fri 22nd May 2020 LamPORE is designed for use in both high-throughput labs or decentralised locations- Oxford Nanopore Technologies is in advanced development of a new generation of end-to-end test (assay) for the detection of SARS-CoV-2, the virus that causes COVID-19. The LamPORE assay is designed to be rapid, low cost, and scalable to cater... Read more

May 22, 2020 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use

Genomics insights generated through sequencing an individual’s DNA play a critical role in personalised healthcare and clinical diagnostics of the future Roche is committed to developing a nanopore sequencer with the aim of providing the healthcare community and ultimately patients with faster and more accurate medical information to predict risk and detect disease This investment... Read more